DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Nasser AF, Heidbreder C, Gomeni R. et al.
A population pharmacokinetic and pharmacodynamic modelling approach to support
the clinical development of RBP-6000, a new, subcutaneously injectable,
long-acting, sustained-release formulation of buprenorphine, for the treatment
of opioid dependence.
Clin Pharmacokinet 2014;
53: 813-824
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.